UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Outcome of Induction Treatment in the Era of Novel Agents and the Impact of the Number of High‐Risk Cytogenetic Abnormalities (HRA) on Prognosis of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Insights From a Multicenter Study

Cancer medicine (Malden, MA), 2024-10, Vol.13 (20), p.e70270-n/a

2024

Volltextzugriff (PDF)

Challenges in the treatment of soft-tissue plasmacytoma: a retrospective analysis of 120 patients with extramedullary multiple myeloma

Journal of cancer research and clinical oncology, 2024-10, Vol.150 (10), p.482, Article 482

2024

Volltextzugriff (PDF)

The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma

Journal of experimental & clinical cancer research, 2024-11, Vol.43 (1), p.294-17, Article 294

2024

Volltextzugriff (PDF)

Characteristics and treatment patterns of long-surviving patients with multiple myeloma: over 13 years of follow-up in the Connect® MM Registry

Clinical lymphoma, myeloma and leukemia, 2024-11

2024

Volltextzugriff (PDF)

Long non-coding RNA NEAT1 promotes multiple myeloma malignant transformation via targeting miR-485-5p/ABCB8

Hematology (Luxembourg), 2024-12, Vol.29 (1), p.2422153

2024

Volltextzugriff (PDF)

Identifying the prognostic significance of mitophagy-associated genes in multiple myeloma: a novel risk model construction

Clinical and experimental medicine, 2024-10, Vol.24 (1), p.249, Article 249

2024

Volltextzugriff (PDF)

Cryoglobulinemia Associated With Multiple Myeloma in a Dog Presenting With Epistaxis and Skin Lesions

Veterinary medicine and science, 2024-11, Vol.10 (6), p.e70084-n/a

2024

Volltextzugriff (PDF)

Wound healing after surgical therapy for multiple myeloma: a case-control study

Journal of wound care, 2024-11, Vol.33 (11), p.866-874

2024

Volltextzugriff (PDF)

Light chain amyloidosis with cuticular cysts as the initial symptom complicated with multiple myeloma: report of a case

Zhonghua bing li xue za zhi, 2024-11, Vol.53 (11), p.1150

2024

Volltextzugriff (PDF)

A single-cell transcriptomic map of the murine and human multiple myeloma immune microenvironment across disease stages

Journal of hematology and oncology, 2024-11, Vol.17 (1), p.1-22, Article 107

2024

Volltextzugriff (PDF)

Flow Cytometric MRD Detection in Selected Mature B-Cell Malignancies

Methods in molecular biology (Clifton, N.J.), 2025, Vol.2865, p.145

2025

Volltextzugriff (PDF)

A systematic review on the epidemiology and treatment options of multiple Myeloma in Asia

Heliyon, 2024-11, Vol.10 (21), p.e39698, Article e39698

2024

Volltextzugriff (PDF)

Bilateral exudative retinal detachment with subretinal light-chain protein in a patient with multiple myeloma -case report

BMC ophthalmology, 2024-10, Vol.24 (1), p.474-5, Article 474

2024

Volltextzugriff (PDF)

Secondary Cutaneous Plasmacytoma Occurring in a Knee Arthrotomy Scar: A Case Report

Indian journal of dermatology, 2024-11, Vol.69 (6), p.481-483

2024

Volltextzugriff (PDF)

Linvoseltamab Still Efficacious Despite CRL in Multiple Myeloma: I don't think [the CRL] impacts how I look at the data that [are] publicly available or the long-term approval chances for linvoseltamab and how we might use it in the future," said Surbhi Sidana, MD

Oncology (Williston Park, N.Y.), 2024-10, Vol.38 (10), p.384

Sidana, Surbhi

2024

Volltextzugriff (PDF)

The experiences of living with multiple myeloma and a palliative approach to care: A grounded theory study

Canadian Oncology Nursing Journal, 2024-11, Vol.34 (4), p.539-549

2024

Volltextzugriff (PDF)

Correction to “Clinical Outcome of Induction Treatment in the Era of Novel Agents and the Impact of the Number of High‐Risk Cytogenetic Abnormalities (HRA) on Prognosis of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Insights From a Multicenter Study”

Cancer medicine (Malden, MA), 2024-11, Vol.13 (21), p.n/a

2024

Volltextzugriff (PDF)

Difficult To Diagnose Plasmocytoma With Atypical Clinical Presentation In An Older Patient: A Case Report

Geriatrics, Gerontology and Aging (Online), 2024-10, Vol.12, p.50-53

2024

Volltextzugriff (PDF)

Melanoma Antigen Genes (MAGE); novel functional targets in Multiple Myeloma

Seminars in hematology, 2024-10

2024

Volltextzugriff (PDF)

In vitro testing of drug response in primary multiple myeloma cells using a microwell-based technology

Leukemia research, 2024-12, Vol.147, p.107599, Article 107599

2024

Volltextzugriff (PDF)

Bortezomib-based regimen affects cognitive functions in multiple myeloma patients through the VEGF pathway – Hypothesis that connects different knowledge streams

Medical hypotheses, 2024-12, Vol.193, p.111510, Article 111510

2024

Volltextzugriff (PDF)

Smoldering Multiple Myeloma: Integrating Biology and Risk into Management

Seminars in hematology, 2024-10

2024

Volltextzugriff (PDF)

Oncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patients

Frontiers in immunology, 2024-10, Vol.15

2024

Volltextzugriff (PDF)

Osteosclerosing multiple myeloma: A case highlighting critical value of image findings for the diagnosis

Radiology case reports, 2025-01, Vol.20 (1), p.545-549

2025

Volltextzugriff (PDF)

Real-World Outcomes of Upfront Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma With Deletion 17p

Transplantation and cellular therapy, 2024-10

2024

Volltextzugriff (PDF)

1 – 25 von 152

Suche als RSS-Feed

Aktive Filter

KollektionNature Research

Neu hinzugefügt... seit 30 Tagen

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(78)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Clinical Outcome of Induction Treatment in the Era of Novel Agents and the Impact of the Number of High‐Risk Cytogenetic Abnormalities (HRA) on Prognosis of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Insights From a Multicenter Study

Challenges in the treatment of soft-tissue plasmacytoma: a retrospective analysis of 120 patients with extramedullary multiple myeloma

The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma

Characteristics and treatment patterns of long-surviving patients with multiple myeloma: over 13 years of follow-up in the Connect® MM Registry

Long non-coding RNA NEAT1 promotes multiple myeloma malignant transformation via targeting miR-485-5p/ABCB8

Identifying the prognostic significance of mitophagy-associated genes in multiple myeloma: a novel risk model construction

Cryoglobulinemia Associated With Multiple Myeloma in a Dog Presenting With Epistaxis and Skin Lesions

Wound healing after surgical therapy for multiple myeloma: a case-control study

Light chain amyloidosis with cuticular cysts as the initial symptom complicated with multiple myeloma: report of a case

A single-cell transcriptomic map of the murine and human multiple myeloma immune microenvironment across disease stages

Flow Cytometric MRD Detection in Selected Mature B-Cell Malignancies

A systematic review on the epidemiology and treatment options of multiple Myeloma in Asia

Bilateral exudative retinal detachment with subretinal light-chain protein in a patient with multiple myeloma -case report

Secondary Cutaneous Plasmacytoma Occurring in a Knee Arthrotomy Scar: A Case Report

Linvoseltamab Still Efficacious Despite CRL in Multiple Myeloma: I don't think [the CRL] impacts how I look at the data that [are] publicly available or the long-term approval chances for linvoseltamab and how we might use it in the future," said Surbhi Sidana, MD

The experiences of living with multiple myeloma and a palliative approach to care: A grounded theory study

Correction to “Clinical Outcome of Induction Treatment in the Era of Novel Agents and the Impact of the Number of High‐Risk Cytogenetic Abnormalities (HRA) on Prognosis of Patients With Newly Diagnosed Multiple Myeloma (NDMM): Insights From a Multicenter Study”

Difficult To Diagnose Plasmocytoma With Atypical Clinical Presentation In An Older Patient: A Case Report

Melanoma Antigen Genes (MAGE); novel functional targets in Multiple Myeloma

In vitro testing of drug response in primary multiple myeloma cells using a microwell-based technology

Bortezomib-based regimen affects cognitive functions in multiple myeloma patients through the VEGF pathway – Hypothesis that connects different knowledge streams

Smoldering Multiple Myeloma: Integrating Biology and Risk into Management

Oncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patients

Osteosclerosing multiple myeloma: A case highlighting critical value of image findings for the diagnosis

Real-World Outcomes of Upfront Autologous Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma With Deletion 17p

Aktive Filter

Suchergebnisse filtern